Abiopharma

PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market

Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)

IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors

IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors USA - English Israel - English

Neogen® Announces Two Senior Leadership Appointments

CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules